Eli Lilly announces direct-to-patient portal for new weight loss drug; The latest health stories from around the world

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Eli Lilly, maker of the anti-obesity drug Zepbound, announced last week the launch of LillyDirect, a direct-to-patient portal, allowing some patients to obtain its drug for as little as $25 a month.  The move is seen as a major shift in the way …

Eli Lilly announces direct-to-patient portal for new weight loss drug; The latest health stories from around the world Read More »